SR-BII, AN ISOFORM OF THE SCAVENGER RECEPTOR BI CONTAINING AN ALTERNATE CYTOPLASMIC TAIL, MEDIATES LIPID TRANSFER BETWEEN HIGH-DENSITY-LIPOPROTEIN AND CELLS
Nr. Webb et al., SR-BII, AN ISOFORM OF THE SCAVENGER RECEPTOR BI CONTAINING AN ALTERNATE CYTOPLASMIC TAIL, MEDIATES LIPID TRANSFER BETWEEN HIGH-DENSITY-LIPOPROTEIN AND CELLS, The Journal of biological chemistry, 273(24), 1998, pp. 15241-15248
The scavenger receptor class B, type I (SR-BI), binds high density lip
oprotein (HDL) and mediates selective uptake of cholesteryl ester from
HDL and HDL-dependent cholesterol efflux from cells. We recently iden
tified a new mRNA variant that differs from the previously characteriz
ed form in that the encoded C-terminal cytoplasmic domain is almost co
mpletely different. In the present study, we demonstrate that the mRNA
s for mouse SR-BI and SR-BII (previously termed SR-BI.2) are the alter
natively spliced products of a single gene. The translation products p
redicted from human, bovine, mouse, hamster, and rat cDNAs exhibit a h
igh degree of sequence similarity within the SR-BII C-terminal domain
(62-67% identity when compared with the human sequence), suggesting th
at this variant is biologically important. SR-BII protein represents a
pproximately 12% of the total immunodetectable SR-BI/II protein in mou
se liver. Subcellular fractionation of transfected Chinese hamster ova
ry cells showed that SR-BII, like SR-BI, is enriched in caveolae, indi
cating that the altered cytoplasmic tail does not affect targeting of
the receptor. SR-BII mediated both selective cellular uptake of choles
teryl ether from HDL as well as HDL-dependent cholesterol efflux from
cells, although with approximately 4-fold lower efficiency than SR-BI,
In vivo studies using adenoviral vectors showed that SR-BII was relat
ively less efficient than SR-BI in reducing plasma HDL cholesterol, Th
ese studies show that SR-BII, an HDL, receptor isoform containing a di
stinctly different cytoplasmic tail, mediates selective lipid transfer
between HDL and cells, but with a lower efficiency than the previousl
y characterized variant.